Abstract | PURPOSE: METHODS: COX-2 expression was assessed by RT-PCR and Western blotting. PGE2/ PGD2 levels in cell culture supernatants and DNA fragmentation were measured by ELISA. RESULTS: CONCLUSION: This study demonstrates COX-2 induction and synthesis of L-PGDS-derived, PPARgamma-activating PGs as a possible mechanism of apoptosis by MA.
|
Authors | Karin Eichele, Robert Ramer, Burkhard Hinz |
Journal | Pharmaceutical research
(Pharm Res)
Vol. 26
Issue 2
Pg. 346-55
(Feb 2009)
ISSN: 0724-8741 [Print] United States |
PMID | 19015962
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Arachidonic Acids
- Cyclooxygenase 2 Inhibitors
- Fumonisins
- Lipocalins
- Nitrobenzenes
- PPAR gamma
- RNA, Messenger
- RNA, Small Interfering
- Sulfonamides
- N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
- methanandamide
- fumonisin B1
- Oxidoreductases
- Cyclooxygenase 2
- PTGS2 protein, human
- dihydroceramide desaturase
- Intramolecular Oxidoreductases
- prostaglandin R2 D-isomerase
- Dinoprostone
- Prostaglandin D2
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Arachidonic Acids
(pharmacology)
- Cyclooxygenase 2
(genetics, metabolism)
- Cyclooxygenase 2 Inhibitors
(pharmacology)
- DNA Fragmentation
- Dinoprostone
(metabolism)
- Dose-Response Relationship, Drug
- Female
- Fumonisins
(pharmacology)
- Gene Expression Regulation, Enzymologic
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- HeLa Cells
- Humans
- Intramolecular Oxidoreductases
(metabolism)
- Lipocalins
(metabolism)
- Nitrobenzenes
(pharmacology)
- Oxidoreductases
(antagonists & inhibitors, metabolism)
- PPAR gamma
(metabolism)
- Prostaglandin D2
(metabolism)
- RNA Interference
- RNA, Messenger
(metabolism)
- RNA, Small Interfering
(metabolism)
- Sulfonamides
(pharmacology)
- Time Factors
- Uterine Cervical Neoplasms
(enzymology, genetics, pathology)
|